Nuveen Asset Management’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | $30.4M | Sell |
1,743,190
-88,913
| -5% | -$1.55M | 0.01% | 908 |
|
2024
Q3 | $25.6M | Buy |
1,832,103
+1,094,465
| +148% | +$15.3M | 0.01% | 1020 |
|
2024
Q2 | $6.06M | Buy |
737,638
+6,260
| +0.9% | +$51.5K | ﹤0.01% | 1848 |
|
2024
Q1 | $5.64M | Buy |
731,378
+247,050
| +51% | +$1.9M | ﹤0.01% | 1928 |
|
2023
Q4 | $4.35M | Sell |
484,328
-220,975
| -31% | -$1.99M | ﹤0.01% | 2059 |
|
2023
Q3 | $6.31M | Sell |
705,303
-185,474
| -21% | -$1.66M | ﹤0.01% | 1748 |
|
2023
Q2 | $13.7M | Buy |
890,777
+563,124
| +172% | +$8.65M | ﹤0.01% | 1311 |
|
2023
Q1 | $7.37M | Buy |
327,653
+143,585
| +78% | +$3.23M | ﹤0.01% | 1662 |
|
2022
Q4 | $4.54M | Sell |
184,068
-225,420
| -55% | -$5.56M | ﹤0.01% | 1968 |
|
2022
Q3 | $10.1M | Sell |
409,488
-27,469
| -6% | -$677K | ﹤0.01% | 1467 |
|
2022
Q2 | $10.8M | Buy |
436,957
+28,988
| +7% | +$715K | ﹤0.01% | 1453 |
|
2022
Q1 | $10.1M | Sell |
407,969
-9,855
| -2% | -$243K | ﹤0.01% | 1634 |
|
2021
Q4 | $10.3M | Sell |
417,824
-58,721
| -12% | -$1.45M | ﹤0.01% | 1671 |
|
2021
Q3 | $11.8M | Sell |
476,545
-196,772
| -29% | -$4.85M | ﹤0.01% | 1667 |
|
2021
Q2 | $16.6M | Sell |
673,317
-193,909
| -22% | -$4.78M | ﹤0.01% | 1512 |
|
2021
Q1 | $21.4M | Buy |
867,226
+106,204
| +14% | +$2.62M | 0.01% | 1268 |
|
2020
Q4 | $18.8M | Buy |
761,022
+44,871
| +6% | +$1.11M | 0.01% | 1304 |
|
2020
Q3 | $13.2M | Buy |
716,151
+120,618
| +20% | +$2.23M | 0.01% | 1333 |
|
2020
Q2 | $12.2M | Buy |
595,533
+34,000
| +6% | +$694K | ﹤0.01% | 1356 |
|
2020
Q1 | $8.19M | Buy |
561,533
+4,547
| +0.8% | +$66.3K | ﹤0.01% | 1418 |
|
2019
Q4 | $7.91M | Sell |
556,986
-16,089
| -3% | -$228K | ﹤0.01% | 1730 |
|
2019
Q3 | $6.64M | Sell |
573,075
-137,386
| -19% | -$1.59M | ﹤0.01% | 1803 |
|
2019
Q2 | $14.3M | Buy |
+710,461
| New | +$14.3M | 0.01% | 1378 |
|